Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
Not Applicable
Recruiting
- Conditions
- Orbital Neoplasms
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06791226
- Locations
- 🇨🇳
Dept. of Nuclear Medicine, Peking University Third Hospital, Beijing, Beijing, China
PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer
Phase 2
Recruiting
- Conditions
- Gastric Cancer
- Interventions
- Drug: Carilizumab and Apatinib
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06792162
- Locations
- 🇨🇳
Peking University third hospital, Beijing, China
ARTLifeLine: Assisted Reproduction Technology (ART) Family Health and Development Trajectory Cohort (ARTLL)
- Conditions
- Reproductive Techniques, AssistedFamilyCohort StudiesDevelopment, InfantReproductive Issues
- First Posted Date
- 2025-01-22
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 100000
- Registration Number
- NCT06786871
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China, Beijing, Beijing, China
🇨🇳Peking University Third Hospital, Beijing, Beijing, China
Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity
Not Applicable
Not yet recruiting
- Conditions
- Polycystic Ovary SyndromeObesityInfertility, Female
- Interventions
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 392
- Registration Number
- NCT06775093
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Conservative Treatment for Atlantoaxial Dislocation Patients Without Neurological Deficit
Not yet recruiting
- Conditions
- Atlantoaxial Dislocation
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06772311
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Liraglutide Treatment in Obese Infertile PCOS Women
Phase 4
Not yet recruiting
- Conditions
- PCOSObesityInfertility
- Interventions
- First Posted Date
- 2024-12-19
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 890
- Registration Number
- NCT06742710
Prospective Cohort Study on Predicting the Progression of Diabetic Microangiopathy Using Multimodal Eye Imaging
Not yet recruiting
- Conditions
- Diabetic Retinopathy
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT06727955
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Apples in Night Shift
Not Applicable
Not yet recruiting
- Conditions
- Night Work
- First Posted Date
- 2024-12-03
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06714422
Minimally Invasive Atlantoaxial Lateral Mass Joint Fusion (MIS-PALF) As a Surgical Treatment of Atlantoaxial Dislocation
Not Applicable
Not yet recruiting
- Conditions
- Atlantoaxial Dislocation
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06678711
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Evaluation of Long-term Isokinetic Training of Knee Joint
Not Applicable
Recruiting
- Conditions
- Knee Injuries and Disorders
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT06674473
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath